Further clinical studies revealed that high expression of EZH2 stratified the HCC patients into those with elevated neoplasm disease stage (Figure S2A), enhanced cancer progression (Figure S2, B), and high histologic grade (Figure S2C). The gene discussed is EZH2; the disease is hepatocellular carcinoma.